MetLife amends $4.0B revolver, extendable to $5.5B, maturing November 2031

METLIFE INC

Amended and restated credit agreement dated November 9, 2026 provides $4,000,000,000 of borrowings and letters of credit, upsizable to $5,500,000,000 absent an event of default.
Borrowings must be repaid by November 7, 2031; letters of credit outstanding that day may remain until November 7, 2032. Proceeds for general corporate purposes.
Pricing set at Level 3 (A-/A3) at closing: 8.0bp commitment fee, Term SOFR +100bp, 87.5bp L/C fee; grid falls to 6.0bp/75bp/62.5bp at A+/A1 or better.
Bank of America is administrative agent; Wells Fargo and JPMorgan Chase are co-syndication agents; BofA Securities, Wells Fargo Securities and JPMorgan are joint lead arrangers.
Borrowers are MetLife, Inc. and wholly-owned subsidiary MetLife Funding, Inc., replacing the prior facility dated May 8, 2023.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.